On Sunday, September 8, a 27-year-old Loyola Medicine patient will meet for the first time the Arizona man who donated bone marrow on three separate occasions to help save her life.
Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19. The findings, published in Nature, may lead to new therapeutic treatment options.
20240326113011.png&width=400&height=400){kind=logo}
Looking to extend the viability of human tissues, researchers report in ACS’ Nano Letters their efforts to facilitate completely freezing, rather than cooling and then thawing, potentially life-saving organs for transplant. They demonstrate a magnetic nanoparticle’s successful rewarming of animal tissues.
Sadly, only 20 percent of lung transplant recipients survive beyond the 10-year mark, a fact that is not lost on Diane Williams as she celebrates the tenth anniversary of her transplant. After suffering from idiopathic pulmonary fibrosis, a debilitating lung disease that causes scarring of the lungs, Williams received a life-saving lung transplant in 2014.
Researchers from Michigan State University and Corewell Health, in collaboration with Cleveland Clinic, have made a significant breakthrough in understanding post-COVID-19 lung complications.
Researchers determined that transplant patients who receive kidneys infected with the parasite toxoplasma have virtually the same outcomes as those who receive toxoplasma-negative organs.
Liver transplant is considered the best treatment for liver cancer, but only available for patients with early-stage disease. Now a study led by Cedars-Sinai Cancer investigators has concluded that immunotherapy could make liver transplant an option for patients with later-stage cancer as well.
A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body’s different blood cells.
The UCSF Lung Transplant Program has performed over 100 transplants in a year, making it one of a handful of medical centers in the nation to reach that milestone.
Dr. Vikas Dharnidharka will join Rutgers Robert Wood Johnson Medical School as Henry Rutgers Professor and chair of the Department of Pediatrics and also will serve as physician-in-chief of The Bristol-Myers Squibb Children’s Hospital (BMSCH) at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
Thermo Fisher Scientific Inc. will showcase its broad diagnostics portfolio and host a series of customer-led workshops and presentations that highlight industry developments and the company’s latest innovations during the Association for Diagnostics & Laboratory Medicine Conference (ADLM) July 28-Aug. 1, 2024, in Chicago, Ill.
Two recent grants from the National Institutes of Health (NIH) and American Heart Association are helping fund research of a novel vascular stent being developed at The Ohio State University Wexner Medical Center. The multi-use retrievable stent has the potential to save lives by improving vascular surgery and drug delivery as well as expanding organ donation.
The Vanderbilt Transplant Center performed a record number of solid organ transplants in fiscal year 2024 — 809 life-saving procedures among its adult and pediatric programs. The adult program performed 760 transplants, and the pediatric program completed 49 transplants during the fiscal year, which ran from July 2023 until the end of June 2024.
Saint Louis University School of Medicine researchers led by Krista Lentine, M.D., Ph.D., professor of medicine, will assess how the use of genetic testing may mitigate racial disparities in the health outcomes of people with chronic kidney disease, including organ donors and transplant recipients.
A Mayo Clinic anuncia uma conquista inovadora no transplante de órgãos, oferecendo esperança a milhares de pessoas que perderam a capacidade de falar, engolir e respirar por conta própria devido à diminuição da função ou perda da laringe.
Mayo Clinic anuncia un logro innovador en el trasplante de órganos, ofreciendo esperanza a miles de personas que han perdido la capacidad de hablar, tragar y respirar por sí mismas debido a la disminución de la función o la pérdida de la laringe.
In a study published today in the journal Clinical Infectious Diseases, a Johns Hopkins Medicine research team reports that for XBB.1.5, there is good news for solid organ transplant recipients (SOTRs) and other immunocompromised people who receive regular booster doses of a messenger RNA (mRNA) bivalent vaccine (a vaccine designed to enhance immunity to a variety of SARS-CoV-2 strains).
Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, has assumed the top volunteer leadership position of the American Society of Transplantation.
Vanderbilt University Medical Center (VUMC) researchers are touting data from a multicenter, international phase 2 clinical trial showing a new, curative treatment for sickle cell disease (SCD).
BACKGROUNDTraumatic brain injury (TBI) is characterized by a disruption in the normal function of the brain due to an injury following a trauma, which can potentially cause severe physical, cognitive, and emotional impairment. Stem cell tra
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right